{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:27:41Z","timestamp":1791329261065,"version":"4.3.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"MD Anderson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["DNA Repair"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.dnarep.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T02:30:31Z","timestamp":1429669831000},"page":"19-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Inhibition of the ERCC1\u2013XPF structure-specific endonuclease to overcome cancer chemoresistance"],"prefix":"10.1016","volume":"31","author":[{"given":"Ewan M.","family":"McNeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy R.","family":"Astell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Bakrania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Wear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm D.","family":"Walkinshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Saxty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dnarep.2015.04.002_bib0260","unstructured":"CancerStats, Cancer Research UK, 2015. http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/wsbm.1210","article-title":"Developing melanoma therapeutics: overview and update","volume":"5","author":"Korman","year":"2013","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0270","doi-asserted-by":"crossref","first-page":"9990","DOI":"10.1093\/nar\/gks818","article-title":"DNA repair endonuclease ERCC1\u2013XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy","volume":"40","author":"McNeil","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0275","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.127.3.978","article-title":"ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer","volume":"127","author":"Simon","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.dnarep.2015.04.002_bib0280","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2407-8-97","article-title":"ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and\/or docetaxel","volume":"8","author":"Wang","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.dnarep.2015.04.002_bib0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1748-717X-7-221","article-title":"ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma","volume":"7","author":"Bai","year":"2012","journal-title":"Radiat. Oncol. Lond. Engl."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0295","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/bjc.2013.576","article-title":"ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial","volume":"109","author":"Bauman","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.dnarep.2015.04.002_bib0300","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2012.05.006","article-title":"Comparison of ERCC1\/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum","volume":"126","author":"Deloia","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0305","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1476-4598-9-248","article-title":"Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1\u2013XPF expression","volume":"9","author":"Usanova","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.dnarep.2015.04.002_bib0310","first-page":"1311","article-title":"Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines","volume":"63","author":"Selvakumaran","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0315","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.dnarep.2010.03.010","article-title":"Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells","volume":"9","author":"Arora","year":"2010","journal-title":"DNA Repair"},{"key":"10.1016\/j.dnarep.2015.04.002_bib0320","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2004.12.008","article-title":"Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin","volume":"327","author":"Chang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0325","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1755-148X.2011.00882.x","article-title":"Identification of DNA repair gene Ercc1 as a novel target in melanoma","volume":"24","author":"Song","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0330","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.0504341102","article-title":"Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1","volume":"102","author":"Tsodikov","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0335","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/sj.emboj.7601894","article-title":"Structural basis for the recruitment of ERCC1\u2013XPF to nucleotide excision repair complexes by XPA","volume":"26","author":"Tsodikov","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0340","first-page":"1849","article-title":"The structure of the human ERCC1\/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair","volume":"13","author":"Tripsianes","year":"2005","journal-title":"Struct. Lond. Engl. 1993"},{"key":"10.1016\/j.dnarep.2015.04.002_bib0345","doi-asserted-by":"crossref","first-page":"28644","DOI":"10.1074\/jbc.M501083200","article-title":"Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF\u2013ERCC1 complex","volume":"280","author":"Choi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0350","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/nar\/29.4.872","article-title":"Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair","volume":"29","author":"Gaillard","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0968-0004(99)01355-9","article-title":"A relationship between a DNA-repair\/recombination nuclease family and archaeal helicases","volume":"24","author":"Sgouros","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0360","first-page":"143","article-title":"Crystal structure and functional implications of Pyrococcus furiosus hef helicase domain involved in branched DNA processing","volume":"13","author":"Nishino","year":"2005","journal-title":"Struct. Lond. Engl. 1993"},{"key":"10.1016\/j.dnarep.2015.04.002_bib0365","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/emboj\/21.8.2045","article-title":"The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif","volume":"21","author":"Enzlin","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0370","first-page":"4529","article-title":"Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins","volume":"59","author":"Jiang","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0375","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jmgm.2009.04.009","article-title":"Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach","volume":"28","author":"Barakat","year":"2009","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0380","doi-asserted-by":"crossref","first-page":"e51329","DOI":"10.1371\/journal.pone.0051329","article-title":"Virtual screening and biological evaluation of inhibitors targeting the XPA\u2013ERCC1 interaction","volume":"7","author":"Barakat","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dnarep.2015.04.002_bib0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/mol.112.082347","article-title":"Small molecule inhibitors of ERCC1\u2013XPF protein\u2013protein interaction synergize alkylating agents in cancer cells","volume":"84","author":"Jordheim","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0390","doi-asserted-by":"crossref","first-page":"26632","DOI":"10.1074\/jbc.C000337200","article-title":"Repair of an interstrand DNA cross-link initiated by ERCC1\u2013XPF repair\/recombination nuclease","volume":"275","author":"Kuraoka","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0395","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/nar\/gks284","article-title":"Fluorescence-based incision assay for human XPF-ERCC1 activity identifies important elements of DNA junction recognition","volume":"40","author":"Bowles","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0400","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ab.2005.06.037","article-title":"A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A","volume":"345","author":"Wear","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0405","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1074\/jbc.273.14.7835","article-title":"DNA structural elements required for ERCC1\u2013XPF endonuclease activity","volume":"273","author":"de Laat","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0410","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.saa.2009.09.024","article-title":"Interaction of aurintricarboxylic acid (ATA) with four nucleic acid binding proteins DNase I, RNase A, reverse transcriptase and Taq polymerase","volume":"74","author":"Ghosh","year":"2009","journal-title":"Spectrochim. Acta. A: Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0415","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/nar\/4.9.3055","article-title":"Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation","volume":"4","author":"Hallick","year":"1977","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0420","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/nar\/gkq1082","article-title":"Complementary non-radioactive assays for investigation of human flap endonuclease 1 activity","volume":"39","author":"Dorjsuren","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0425","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/sj.emboj.7600581","article-title":"Structure of an XPF endonuclease with and without DNA suggests a model for substrate recognition","volume":"24","author":"Newman","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0430","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nprot.2009.2","article-title":"Protein structure prediction on the Web: a case study using the Phyre server","volume":"4","author":"Kelley","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0435","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0440","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1087057109336586","article-title":"Efficient elimination of nonstoichiometric enzyme inhibitors from HTS hit lists","volume":"14","author":"Habig","year":"2009","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0445","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bmcl.2004.10.086","article-title":"The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors","volume":"15","author":"Tumey","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0450","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1002\/j.1460-2075.1993.tb06043.x","article-title":"Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro","volume":"12","author":"Biggerstaff","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0455","doi-asserted-by":"crossref","first-page":"D400","DOI":"10.1093\/nar\/gkr1132","article-title":"PubChem's BioAssay database","volume":"40","author":"Wang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0460","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1093\/nar\/24.17.3370","article-title":"Mutational analysis of the human nucleotide excision repair gene ERCC1","volume":"24","author":"Sijbers","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0465","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1093\/nar\/26.18.4146","article-title":"Mapping of interaction domains between human repair proteins ERCC1 and XPF","volume":"26","author":"de Laat","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0470","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ng1193-217","article-title":"Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning","volume":"5","author":"McWhir","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0475","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0960-9822(06)00190-4","article-title":"Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence","volume":"7","author":"Weeda","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0480","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1087057113476551","article-title":"Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors","volume":"18","author":"McWhirter","year":"2013","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0485","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1016\/j.bmcl.2004.07.028","article-title":"The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors, Bioorg","volume":"14","author":"Tumey","year":"2004","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0490","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/MCB.24.3.1200-1205.2004","article-title":"Growth retardation, early death, and DNA repair defects in mice deficient for the nucleotide excision repair enzyme XPF","volume":"24","author":"Tian","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0495","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/emboj\/cdg206","article-title":"Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse","volume":"22","author":"M\u00e9nissier de Murcia","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0500","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1128\/MCB.23.15.5346-5353.2003","article-title":"Proliferation failure and gamma radiation sensitivity of Fen1 null mutant mice at the blastocyst stage","volume":"23","author":"Larsen","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0505","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1093\/nar\/gkq1304","article-title":"Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells","volume":"39","author":"Zhang","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2015.04.002_bib0510","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1038\/onc.2013.311","article-title":"A high-throughput screen identifies PARP1\/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer","volume":"32","author":"Postel-Vinay","year":"2013","journal-title":"Oncogene"}],"container-title":["DNA Repair"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786415000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786415000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T18:40:28Z","timestamp":1566585628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568786415000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":51,"alternative-id":["S1568786415000865"],"URL":"https:\/\/doi.org\/10.1016\/j.dnarep.2015.04.002","relation":{},"ISSN":["1568-7864"],"issn-type":[{"value":"1568-7864","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the ERCC1\u2013XPF structure-specific endonuclease to overcome cancer chemoresistance","name":"articletitle","label":"Article Title"},{"value":"DNA Repair","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dnarep.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}